WO2005070384A1 - Taurate formulated pigmented cosmetic composition exhibitiing radiance with soft focus - Google Patents
Taurate formulated pigmented cosmetic composition exhibitiing radiance with soft focus Download PDFInfo
- Publication number
- WO2005070384A1 WO2005070384A1 PCT/EP2005/000436 EP2005000436W WO2005070384A1 WO 2005070384 A1 WO2005070384 A1 WO 2005070384A1 EP 2005000436 W EP2005000436 W EP 2005000436W WO 2005070384 A1 WO2005070384 A1 WO 2005070384A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- measured
- angle
- composition according
- composition
- transmission intensity
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/28—Zirconium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8182—Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Definitions
- the invention relates to compositions for improving the appearance of skin, particularly to provide good coverage over imperfections such as pores and uneven skin tone, while retaining a natural skin appearance.
- a matte effect is desired for users of color cosmetics.
- the matte finish overcomes the shiny effect engendered by greasy skin, particularly under hot and humid conditions.
- Absorbent fillers such as talc, silica, kaolin and other inorganic particulates have been used to achieve the effect by their optical properties .
- Imperfect skin can be hidden in two ways through manipulation of light transmission.
- components of the color cosmetic may simply reflect light back toward the source.
- An alternative approach is referred to as achieving a soft focus effect.
- the incoming light is distorted by scattering (lensing) .
- Components of the color cosmetic in this mechanism operate as lenses to bend and twist light into a variety of directions.
- US Patent 5,997,890 (Sine et al.), US Patent 5,972,359 (Sine et al.), and US Patent 6,174,533 Bl (SaNogueira, Jr.) are all directed to topical compositions to provide good coverage of skin imperfections.
- the solution proposed by these documents is the use of a metal oxide with, a refractive index of at least about 2 and a neat primary particle size of from about 100 to about 300 nm.
- Preferred particulates are titanium dioxide, zirconium oxide and zinc oxide.
- Silicone gelling agents such as crosslinked organopolysiloxane elastomers because of their excellent skinfeel properties have been found useful in make-up compositions.
- US Patent 5,266,321 discloses an oily make-up composition comprised of a silicone gel crosslinked elastomer, titanium dioxide, mica and iron oxides.
- Japanese patent application 61-194009 describes a make-up composition comprising a cured organopolysiloxane elastomer powder and pigments which may be selected from talc, titanium dioxide, zinc oxide and iron oxides.
- a cosmetic composition which includes : (i) a crosslinked silicone elastomer; (ii) a zinc oxide or zirconium oxide of average particle size less than 300 nm; (iii) a taurate polymer; and (iv) a cosmetically acceptable carrier system.
- a soft focus effect with radiance can be obtained by a combination of fine particle sized zinc oxide or zirconium oxide suspended with a crosslinked silicone elastomer.
- the zinc oxide or zirconium oxide must have an average particle size less than 300 nm. Absent the elastomer or the oxide, there would be insufficient soft focus effect. Oxide alone is inefficient because of excessive loss of reflectance/radiance .
- a component of the present invention is a crosslinked silicone (organopolysiloxane) elastomer.
- Examples in this respect are addition reaction- curing organopolysiloxane compositions which cure under platinum metal catalysis by the addition reaction between SiH-containing diorganopolysiloxane and organopolysiloxane having silicon- bonded vinyl groups; condensation-curing organopolysiloxane compositions which cure in the presence of an organotin compound by a dehydrogenation reaction between hydroxyl terminated diorganopolysiloxane and SiH-containing diorganopolysiloxane; condensation-curing organopolysiloxane compositions which cure in the presence of an organotin compound or a titanate ester, by a condensation reaction between an hydroxyl terminated diorganopolysiloxane and a hydrolyzable organosilane (this condensation reaction is exemplified by dehydration, alcohol- liberating, oxime-liberating, amine-liberating, amide- liberating, carboxyl-liberating, and ketone-liber
- Addition reaction-curing organopolysiloxane compositions are preferred for their rapid curing rates and excellent uniformity of curing.
- a particularly preferred addition reaction-curing organopolysiloxane composition is prepared from: (A) an organopolysiloxane having at least 2 lower alkenyl groups in each molecule; (B) an organopolysiloxane having at least 2 silicon-bonded hydrogen atoms in each molecule; and (C) a platinum-type catalyst.
- the crosslinked siloxane elastomer of the present invention may either be an emulsifying or non-emulsifying crosslinked organopolysiloxane elastomer or combinations thereof.
- non-emulsifying as used herein, defines crosslinked organopolysiloxane elastomer from which polyoxyalkylene units are absent.
- ' emulsifying as used herein, means crosslinked organopolysiloxane elastomer having at least one polyoxyalkylene (e.g., polyoxyethylene or polyoxypropylene) unit.
- Particularly useful emulsifying elastomers are polyoxyalkylene- modified elastomers formed from divinyl compounds, particularly siloxane polymers with at least two free vinyl groups, reacting with Si-H linkages on a polys loxane backbone.
- the elastomers are dimethyl polysiloxanes crosslinked by Si-H sites on a molecularly spherical MQ resin.
- Preferred silicone elastomers are organopolysiloxane compositions available under the INCI names of dimethicone/vinyl dimethicone crosspoly er, dimethicone crosspolymer and Polysilicone-11. Ordinarily these materials are provided as a 1-30% crosslinked silicone elastomer dissolved or suspended in a dimethicone fluid (visually cyclomethicone) .
- crosslinked silicone elastomer refers to the elastomer alone rather than the total commercial compositions which also include a solvent (e.g. dimethicone) carrier.
- Dimethicone/vinyl dimethicone crosspolymers and dimethicone crosspolymers are available from a variety of suppliers including Dow Corning (9040, 9041, 9045, 9506 and 9509), General Electric (SFE 839) , Shin Etsu (KSG-15, 16, 18 [dimethicone/phenyl vinyl dimethicone crosspolymer] ) , and Grant Industries (GransilTM line of materials) , and lauryl dimethicone/vinyl dimethicone crosspolymers supplied by Shin Etsu (e.g., KSG-31, KSG-32, KSG-41, KSG-42, KSG-43, and KSG-44) .
- Shin Etsu e.g., KSG-31, KSG-32, KSG-41, KSG-42, KSG-43, and KSG-44) .
- silicone elastomer powders include vinyl dimethicone/methicone silesquioxane crosspolymers from Shin-Etsu sold as KSP-100, KSP-101, KSP-102, KSP-103, KSP- 104, KSP-105, and hybrid silicone powders that contain a fluoroalkyl group or a phenyl group sold by Shin-Etsu as respectively KSP-20O and KSP-300.
- the crosslinked silicone elastomers of the present invention may range in concentration from about 0.01 to about 30%, preferably from about 0.1 to about 10%, optimally from about 0.5 to about 2% by weight of the cosmetic composition. These weight values exclude any solvent such as cyclomethicone found in commercial "elastomer" silicones such as the Dow Corning products 9040 and 9045. For instance, the amount of crosslinked silicone elastomer in 9040 and. 9045 is between 12 and 13% by weight. Most preferred as the silicone elastomer is 9045 which has a D5 cyclomethicone swelled elastomer particle size (based on volume and calculated as spherical particles) which averages about 38 micron, and may range from about 25 to about 55 micron.
- a second important component of the present invention is that of a micronized zinc oxide or zirconium oxide having average (number) particle sizes less than 300 nm, preferably less than 200 nm, more preferably less than 100 nm and optimally less than 85 nm.
- the particle sizes can range from about 0.01 to about 280 nm, more preferably from about 1 to about 200 nm, even more preferably from 10 to 95 nm, and optimally from 25 to 75 nm.
- Average particle size for zinc oxide or zirconium oxide assumes a spherical shape and is defined as the diameter of the particle averaged over many particles. The average value is a number average. For spherical particles such as the zinc oxide, laser light scattering is utilized to determine the individual sizes of the particles and generate a particle size distribution plot. Based upon the distribution plot, the average particle size can be determined. In more mathematical terms, the average particle size is a diameter converted from the meso-pore specific surface area determined by the t-plot method (particle size converted excluding the specific surface area of micro pores of less than 20 Angstrom) .
- the amount of the oxide may range from about 0.1 to about 20%, preferably from about 0.5 to about 10%, optimally from about 1 to about 5% by weight of the cosmetic composition.
- the zinc oxide or zirconium oxide particles are applied to skin, it is desirable that they be free of toxic trace metal contaminants.
- a particularly preferred zinc oxide has trace concentrations of lead (less than 20 ppm) , arsenic (less than 3 ppm) , cadmium (less than 15 ppm) and mercury (less than 1 ppm) .
- This material is commercially available from BASF Corporation under the trademark of Z-Cote HP1. These particles are best delivered to the formula as a pre-raix of 5-80% weight by weight suspended in an organic ester base.
- Zinc oxide or zirconium oxide particles of the present invention advantageously but not necessarily are substantially spherical in shape.
- the refractive index of these particles may preferably range from about 1.8 to about 2.3. Measurement of refractive index can be performed according to a method described in J.A. Dean, Ed., Lange's Handbook of Chemistry, 14 th Ed., McGraw Hill, New York 1992, Section 9, Refractometry, incorporated herein by reference .
- a further important component of the invention will be an associative polymer.
- Particularly preferred are taurate homopolymers and copolymers.
- the copolymers are especially useful wherein the taurate repeating monomer unit is acryloyl dimethyl taurate (in either free acid or salt form) .
- Monomers forming the copolymer with taurate may include: styrene, acrylic acid, methacrylic acid, vinyl chloride, vinyl acetate, vinyl pyrrolidone, isoprene, vinyl alcohol, vinyl methylether, chloro-styrene, dialkylamino-styrene, maleic acid, acrylamide, methacrylamide and mixtures thereof.
- the term "acid” means not only the free acid but also C ⁇ -C 30 alkyl esters, anhydrides and salts thereof.
- the salts may be ammonium, alkanolammonium, alkali metal and alkaline earth metal salts. Most preferred are the ammonium and alkanolammonium salts.
- Suitable taurate polymers are those listed in the Table below.
- copolymer is Acryloyl Dimethyltaurate/Vinyl Pyrrolidone Copolymer, which is the INCI nomenclature, for a material supplied by Clariant Corporation under the trademark Aristoflex ® AVC, having the following general formula:
- n and m are integers which may independently vary from 1 to 10,000.
- Number average molecular weight of taurate polymers according to the invention may range from about 1,000 to about 3,000,000, preferably from about 3,000 to about 100,000, optimally from about 10,000 to about 80,000.
- Amounts of the taurate polymer may range from about 0.001 to about 10%, preferably from about 0.01 to about 8%, more preferably from about 0.1 to about 5%, optimally from about 0.2 to about 1% by weight of the composition.
- Optional Particles may range from about 0.001 to about 10%, preferably from about 0.01 to about 8%, more preferably from about 0.1 to about 5%, optimally from about 0.2 to about 1% by weight of the composition.
- compositions according to the present invention is that of a light reflecting platelet shaped particles. These particles will have an average particle size D 50 ranging from about 10,000 to about 30,000 nm.
- the refractive index of these particles are preferred to be at least about 1.8, generally from about 1.9 to about 4, more preferably from about 2 to about 3, optimally between about 2.5 and 2.8.
- Illustrative but not limiting examples of light reflecting particles are bismuth oxychloride (single crystal platelets) and titanium dioxide coated mica.
- Suitable bismuth oxychloride crystals are available from EM Industries, Inc. under the trademarks Biron ® NLY-L-2X CO and Biron ® Silver CO (wherein the platelets are dispersed in castor oil) ; Biron ® Liquid Silver (wherein the particles are dispersed in a stearate ester) ; and
- Nailsyn ® IGO, Nailsyn ® II C2X and Nailsyn ® II Platinum 25 (wherein the platelets are dispersed in nitrocellulose) .
- Most preferred is a system where bismuth oxychloride is dispersed in a C 2 -C 40 alkyl ester such as in Biron ® Liquid Silver.
- titanium dioxide coated mica platelets are materials available from EM Industries, Inc. These include
- Timiron ® MP-10 particle size range 10,000-30,000 nm
- MP-14 (particle size range 5,000-30,000 nm) , Timiron ® MP-30 (particle size range 2,000-20,000 nm) , Timiron ® MP-101 (particle size range 5,000-45,000 nm) , Timiron ® MP-111 (particle size range 5,000-40,000 nm) , Timiron ® MP-1001 (particle size range 5,000-20,000 nm) , Timiron ® MP-155 (particle size range 10,000- 40,000 nm) , Timiron ® MP-175 (particle size range 10,000-40,000), Timiron ® MP-115 (particle size range 10,000-40,000 nm) , and Timiron ® MP-127 (particle size range 10,000-40,000 nm) .
- the weight ratio of titanium dioxide coating to the mica platelet may range from about 1:10 to about 5:1, preferably from about 1:1 to about 1:6, more preferably from about 1:3 to about 1:4 by weight .
- the preferred compositions will generally be substantially free of titanium dioxide outside of that required for coating mica.
- Coatings for mica other than titanium dioxide may also be suitable. Silica coatings are such an alternative.
- the amount of the light reflecting platelet shaped particles may range from about 0.1 to about 5%, preferably from about 0.5 to about 3%, more preferably from about 0.8 to about 2%, optimally from about 1 to about 1.5% by weight of the composition.
- compositions of the present invention will have a Reflectance Intensity as measured at a 30° angle ranging from 140 to 170 thousand Watt-nm/cm 2 .
- Light Transmission Intensity advantageously ranges from 4 to 7 million Watt-nm/cm 2 at an angle of 0°; a Transmission Intensity ranging from 1 to 2 million Watt-nm/cm 2 at a 10° angle; a Transmission Intensity ranging from 120 to 140 thousand Watt-nm/cm 2 at a 30° angle; a Transmission Intensity ranging from 60 to 80 thousand Watt- nm/cm 2 at a 40° angle; and a Transmission Intensity ranging from 40 to 60 thousand Watt-nm/cm 2 at a 50° angle.
- the weight ratio of zinc oxide and zirconium oxide to light reflecting platelet shaped particles may range from about 4:1 to about 1:1, preferably from about 3:1 to about 1.5:1, optimally about 2:1 by weight.
- the amount of silicone elastomer and oxide particles relative to the light reflective platelet shaped particles may be present in a ratio from about 10:1 to about 1:1, preferably from about 6:1 to about 1:1, more preferably from about 5:1 to about 3:1, optimally about 4:1 by weight.
- compositions of the present invention may include a non-coated mica.
- These mica particles can also be platelets but of thinner and smaller particle size than the coated micas mentioned above.
- Particularly preferred is Satin Mica, available from Merck-Rona. These are useful to remove any excessive glitter imparted by the light scattering platelets.
- the particle size of the non-coated mica is no higher than 15,000 nm and an average (volume) particle size ranging from 1,000 to 10,000 nm, preferably from 5,000 to 8,000 nm.
- the amount of the non-coated mica may range from about 0.05 to about 2%, preferably from about 0.1 to about 1.5%, optimally from about 0.4 to about 0.8% by weight of the composition.
- porous spherical particles may also be water-insoluble organic material in the form of polymeric porous spherical particles .
- porous is meant an open or closed cell structure.
- the particles are not hollow beads.
- Average particle size may range from about 0.1 to about 100, preferably from about 1 to about 50, more preferably greater than 5 and especially from 5 to about 15, optimally from about 6 to about 10 um.
- Organic polymers or copolymers are the preferred materials and can be formed from monomers including the acid, salt or ester forms of acrylic acid and methacrylic acid, methylacrylate, ethylacrylate, ethylene, propylene, vinylidene chloride, acrylonitrile, maleic acid, vinyl pyrrolidone, styrene, butadiene and mixtures thereof.
- the polymers are especially useful in cross-linked form.
- Cells of the porous articles may be filled by a gas which can be air, nitirogen or a hydrocarbon.
- Oil Absorbance is a measure of porosity and in the preferred but not limiting embodiment may range from about 90 to about 500, preferably from about 100 to about 200, optimally from about 120 to about 180 ml/100 grams. Density of the particles in the preferred but not limiting embodiment may range from about 0.08 to 0.55, preferably from about 0.15 to 0.48 g/cm 3 .
- Illustrative porous polymers include polymethylmethacrylate and cross-linked polystyrene. Most preferred is polymethyl methacrylate available as Ganzpearl ® GMP 820 available from Prespe-trse, Inc., Piscataway, New Jersey, known also by its INCI name of Methyl Methacrylate Crosspolymer.
- Amounts of the water-insoluble polymeric porous particles may range from about 0.01 to about 10%, preferably from about 0.1 to about 5%, optimally from about 0.3 to about 2% by weight of the composition.
- a crystalline structurant advantageously may be present in compositions according to the present invention.
- the structurant may include both a surfactant and a co-surfactant.
- the nature of the surfactant and co-surfactant will depend upon whether the crystalline structurant is anionic or nonionic.
- the preferred surfactants are C ⁇ 0 -C 22 fatty acids and salts (i.e. soap) thereof and particularly combinations of these materials.
- Typical counterions forming the fatty acid salt are those of ammonium, sodium, potassium, lithium, trialkanolammonium (e.g. triethanolammonium) and combinations thereof.
- Amounts of the fatty acid to the fatty acid salt when both present may range from about 100:1 to about 1:100, preferably from about 50:1 to about 1:50, and optimally from about 3:1 to about 1:3 by weight.
- Illustrative fatty acids include behenic acid, stearic acid, isostearic acid, myristic acid, lauric acid, linoleic acid, oleic acid, hydroxystearic acid and combinations thereof. Most preferred is stearic acid. Among the fatty acid salts the most preferred is sodium stearate.
- the co-surfactant for an anionic crystalline structurant typically is a C ⁇ o-C 22 fatty alcohol, a C ⁇ -C 20 o ester of a C ⁇ 0 -C 22 fatty acid and particularly combinations of these materials .
- Relative amounts of the ester to the alcohol when both present may range from about 100:1 to about 1:100, preferably from about 50:1 to about 1:50, and optimally from about 3:1 to about 1:3 by weight.
- Typical fatty alcohols include behenyl alcohol, stearyl alcohol, cetyl alcohol, myristyl alcohol, lauryl alcohol, oleyl alcohol and combinations thereof.
- Esters of the fatty acid preferably are polyol esters such as C 2 -C 3 alkoxylated alcohol esters.
- polyethoxy, polypropoxy and block polyethoxy/polypropoxy alcohol esters are particularly preferred.
- esters as PEG-100 stearate, PEG-20 stearate, PEG-80 laurate, PEG-20 laurate, PEG-100 palmitate, PEG-20 palmitate and combinations thereof.
- the relative amount of surfactant and co-surfactant for the anionz c structurant may range from about 50:1 to about 1:50, preferably from about 10:1 to about 1:10, and optimally from about 3:1 to about Is 3 by weight.
- Nonionic type crystalline structurant will have a surfactant and a co-surfactant different than that for the anionic systems .
- Preferred nonionic structurant surfactants are C ⁇ -C 20 o esters of C ⁇ Q - C 22 fatty acid.
- Esters of the fatty acid preferably are polyol esters such as C 2 -C 3 alkoxylated alcohol or sorbitol esters. Among these are the polyethoxy, polypropoxy and block polyethyoxy/polypropoxy alcohol esters.
- esters as Polysorbate 40, Polysorbate 60, PEG-100 stearate, PEG-20 stearate, PEG-80 laurate, PEG-20 laurate, PEG-100 palmitate, PEG-20 palmitate and combinations thereof.
- the co-surfactant of a nonionic structurant typically may be a combination of a C ⁇ 0 -C 22 fatty alcohol, glyceryl esters of a C10-C22 fatty acid, and a C ⁇ 0 -C 22 unesterified fatty acid.
- Relative amounts of the ester to the alcohol may range from about 100:1 to about 1:100, preferably from about 50:1 to about 1:50, and optimally from about 3:1 to about 1:3 by weight .
- Relative amounts of tie combination of glyceryl ester and fatty alcohol to unesterified fatty acid may range from about 100:1 to about 1:100, preferably from about 50:1 to about 1:50, and optimally from about 3:1 to about 1:3 by weight.
- Typical fatty alcohols include behenyl alcohol, stearyl alcohol, cetyl alcohol, myristyl alcohol, lauryl alcohol, oleyl alcohol and combinations thereof.
- the relative amount of surfactant and co-surfactant in a nonionic structurant may range from about 50:1 to about 1:50, preferably from about 10:1 to about 1:10, and optimally from about 3:1 to about 1:3 by weight.
- a crystalline structurant is formed by the surfactant and co- surfactant.
- the surfactant and co-surfactant combination in their relative ratio and type of material is defined by an enthalpy which may range from about 2 to about 15, preferably from about 2.5 to about 12, and optimally from about 3.5 to about 8 Joules per gram, as measured by Differential Scanning Calorimetry.
- the crystalline structurant system advantageously may have a melting point ranging from about 30 to about 70°C, preferably from about 45 to about 65°C, and optimally from about 50 to about 60°C.
- a rheometer that has a shear rate mode capability and a normal force transducer is utilized to measure the high shear normal force. These devices are available from Rheometric Scientific ARES, TA Instruments AR2000, and Paar Physica MCR. Samples are compressed between concentric parallel plates of diameter 25 mm and gap (vertical distance between the two plates) of 100 microns. The measurements are made in a continuous logarithmic shear sweep mode with a shear rate range of 1 to 10,000 s "1 . Each sweep takes 5 minutes and is conducted at ambient condition (20- 25°C) .
- the normal force is calculated by subtracting the baseline (defined as the normal force value at or near 100 s "1 ) from the highest normal force value measured between 1000 and 10,000 s "1 .
- a positive normal force of 5 grams and especially 10 grams or greater is correlated to products/materials with silky sensations during rubbing in application.
- soft focus is enhanced when the normal force ranges from about +5 to about +100 grams.
- Particularly desirable is a positive normal force in the range from about +10 to about +60, optimally from about +25 to about +40 grams.
- compositions of the present invention may be present in the compositions of the present invention. Foremost is that of water which serves as a carrier in the carrier system. Amounts of water may range from about 1 to about 90%, preferably from about 30 to about 80%, optimally from about 50 to about 80% by weight of the composition.
- Emollient materials may be included as carriers in compositions of this invention. These may be in the form of silicone oils, synthetic esters and hydrocarbons. Amounts of the emollients may range anywhere from about 0.1 to about 95%, preferably between about 1 and about 50% by weight of the composition.
- Silicone oils may be divided into the volatile and nonvolatile variety.
- volatile refers to those materials which have a measurable vapor pressure at ambient temperature (20-25°C) .
- Volatile silicone oils are preferably chosen from cyclic (cyclomethicone) or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms.
- Nonvolatile silicone oils useful as an emollient material include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers.
- the essentially nonvolatile polyalkyl siloxanes useful herein include, for example, polydimethyl siloxanes witri viscosities of from about 5 x 10 "s to 0.1 m 2 /s at 25°C.
- the preferred nonvolatile emollients useful in the present compositions are the polydimethyl siloxanes having viscosities from about 1 x 10 "5 to about 4 x 10 "4 m 2 /s at 25°C.
- ester emollients are:
- Alkenyl or alkyl esters of fatty acids having 10 to 20 carbon atoms examples thereof include isoarachidyl neopentanoate, isononyl isonanonoate, oleyl myristate, oleyl stearate, and oleyl oleate.
- Ether-esters such as fatty acid esters of ethoxylated fatty alcohols.
- Ethylene glycol mono and ⁇ i-fatty acid esters diethylene glycol mono- and di-fatty a_cid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, jpolypropylene glycol 2000 monooleate, polypropylene glycol 2000 rnonostearate, ethoxylated propylene glycol rnonostearate, glyceryl mono- and di- fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl mono-stearate, 1,3-butylene glycol rnonostearate, 1,3- butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters. Particularly useful are pentaerythritol,
- Wax esters such as beeswax, spermaceti wax and tribehenin wax.
- Sterols esters of which cholesterol fatty acid esters are examples thereof .
- Sugar ester of fatty acids such as sucrose polybehenate and sucrose polycottonseedate.
- Hydrocarbons which are suitable cosmetically acceptable carriers include petrolatum, mineral oil, Cn-C ⁇ 3 isoparaffins, polyalphaolefins, and especially isohexadecane, available commercially as Permethyl 101A from Presperse Inc.
- Humectants of the polyhydric alcohol-type can be employed as cosmetically acceptable carriers.
- Typical polyhydric alcohols include polyalkylene glycols and more preferably alkylene polyols and their derivatives, including propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol and derivatives thereof, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3- butylene glycol, isoprene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof.
- the amount of humectant may range anywhere from 0.5 to 50%, preferably between 1 and 15% by weight of the composition. Most preferred is glycerol (also known as glycerin) . Amounts of glycerin may range from about 10% to about 50%, preferably from 12 to 35%, optimally from 15 to 30% by weight of the composition.
- Sunscreen actives may also be included in compositions of the present invention. These will be organic compounds having at least one chromophoric group absorbing within the ultraviolet ranging from 290 to 400 nm. Chromophoric organic sunscreen agents may be divided into the following categories (with specific examples) including: p- aminobenzoic acid, its salts and its derivatives (ethyl, isobutyl, glyceryl esters; p-dimethylaminobenzoic acid) ; anthranilates (o- aminobenzoates; methyl, menthyl, phenyl, benzyl, phenylethyl, linalyl, terpinyl, and cyclohexenyl esters); salicylates (octyl, amyl, phenyl, benzyl, menthyl, glyceryl, and dipropyleneglycol esters) ; cinnamic acid derivatives (menthyl and benzyl esters
- 2-naphthol-6,8-disulfonic acids dihydroxy-naphthoic acid and its salts; o- and p-hydroxybiphenyldisulfonates; coumarin derivatives (7-hydroxy, 7-methyl, 3-phenyl) ; diazoles (2-acetyl-3-bromoindazole, phenyl benzoxazole, methyl naphthoxazole, various aryl benzothiazoles) ; quinine salts (bisulfate, sulfate, chloride, oleate, and tannate) ; quinoline derivatives (8-hydroxyquinoline salts, 2-phenylquinoline) ; hydroxy- or methoxy-substituted benzophenones; uric and vilouric acids; tannic acid and its derivatives (e.g., hexaethylether) ; (butyl carbityl) (6-propyl piperonyl)
- 2-ethylhexyl p- methoxycinnamate 4,4'-t-butyl methoxydibenzoylmethane, 2-hydroxy-4- methoxybenzophenone, octyldimethyl p-aminobenzoic acid, digalloyltrioleate, 2,2-dihydroxy-4-methoxybenzophenone, ethyl 4- [bis (hydroxypropyl) ] aminobenzoate, 2-ethylhexyl-2-cyano-3 , 3 - diphenylacrylate, 2-ethylhexylsalicylate, glyceryl p-aminobenzoate,
- Amounts of the organic sunscreen agent will range from about 0.1 to about 15%, preferably from about 0.5% to about 10%, optimally from about 1% to about 8% by weight of the composition.
- Preservatives can desirably be incorporated into the cosmetic compositions of this invention to protect against the growth of potentially harmful microorganisms.
- Suitable traditional preservatives for compositions of this invention are alkyl esters of para-hydroxybenzoic acid.
- Other preservatives which have more recently come into use include hydantoin derivatives, propionate salts, and a variety of quaternary ammonium compounds.
- Cosmetic chemists are familiar with appropriate preservatives and routinely choose them to satisfy the preservative challenge test and to provide product stability.
- Particularly preferred preservatives are phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, sodium dehydroacetate and benzyl alcohol.
- the preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other ingredients in the emulsion. Preservatives are preferably employed in amounts ranging from 0.01% to 2% by weight of the composition.
- compositions of the present invention may also contain vitamins.
- Illustrative water-soluble vitamins are Niacinamide, Vitamin B 2 , Vitamin B 6 , Vitamin C and Biotin.
- useful water-insoluble vitamins are Vitamin A (retinol) , Vitamin A Palmitate, ascorbyl tetraisopalmitate, Vitamin E (tocopherol) , Vitamin E Acetate and DL- panthenol.
- Total amount of vitamins when present in compositions according to the present invention may range from 0.001 to 10%, preferably from 0.01% to 1%, optimally from 0.1 to 0.5% by weight of the composition.
- Desquamation agents are further optional components.
- Illustrative are the alpha-hydroxycarboxylic acids and beta-hydroxycarboxylic acids and salts of these acids. Among the former are salts of glycolic acid, lactic acid and malic acid.
- Salicylic acid is representative of the beta-hydroxycarboxylic acids. Amounts of these materials when present may range from about 0.1 to about 15% by weight of the composition.
- a variety of herbal extracts may optionally be included in compositions of this invention.
- Illustrative are pomegranate, white birch (Betula Alba) , green tea, chamomile, licorice and extract combinations thereof.
- the extracts may either be water soluble or water-insoluble carried in a solvent which respectively is hydrophilic or hydrophobic. Water and ethanol are the preferred extract solvents.
- Opacity is the measure of intensity attenuation of a transmitted light beam shone perpendicular to a medium or film. The higher the direct beam attenuation, the greater will be the opacity.
- the source of the light beam attenuation is two fold: A) Some of the original light is reflected back from the film/medium. This gives the film/medium a true white/opaque appearance with great hiding power. Using pigment-grade Ti0 2 in a formulation will give the effect. B) Some of the light is deflected from the straight beam path but still transmitted through the film/medium. In effect, the film/medium goes from being transparent to translucent, creating a "blurred" image. Another term for this is soft focus.
- Intensity Values reported herein is turned on and the measurement of the transmitted light intensity is made. Further measurements are made by moving the detector 10, 30, 40, 50 degrees away from the direct transmission normal. These values indicate the extent of soft focus light scattering.
- Reflectance or "radiance" of a product is determined in the same way as opacity/soft focus light scattering, except for the positions of the light source and detector.
- the detector is 30 degrees on one side of the normal/perpendicular, while the light source is 20 degrees on the other side.
- To determine the extent of the intensity attenuation compare the intensity value to that of an uncoated overhead transparency. The difference between these two values is the extent of the attenuation or opacity.
- Sample 1 is a preferred embodiment of the present invention.
- Transmission Intensity (Opacity) at all angles and Reflection Intensity for this formula fell within the parameters necessary to achieve both soft focus and radiance.
- Replacement of the silicone elastomer (Dow Corning 9045) with cyclopentasiloxane (Dow Corning 245) in Sample 2 resulted in a Transmission Intensity at four angles outside the acceptability ranges .
- the zinc oxide was omitted.
- the Transmission Intensity was also outside four of the acceptable ranges indicating the necessity of zinc oxide to achieve soft focus.
- Removal of Ganzpearl ® GMP-0820, which consists of polymethylmethacrylate beads, in Sample 4 had essentially no effect on the opacity.
- Sample 5 wherein Satin Mica was removed as expected demonstrated greater light transmission, but the Reflection Intensity and the 0° angle Transmission Intensity were outside the acceptable range.
- Sample 6 the amount of Aristoflex AVC ® (taurate copolymer) was halved. The 0° angle and 30° angle Transmission Intensity values were outside the acceptable range indicating that this copolymer had an influence and contributed to the soft focus effect .
- Sample 7 formulated with Aristoflex AVC ® in amount between those of Samples 1 and 6 is a further example of how this copolymer is functionally important for soft focus .
- Sample 8 On an equivalent weight basis Sample 8 provided a Transmission Intensity which was within the acceptability range. By contrast, the titanium dioxide formulated Sample Nos. 9, 10 and 11 exhibited Transmission Intensity values outside the acceptable range.
- Samples 13, 16 and 18 were all unstable with either initial phase separation (between oil and water) at 75°C or exhibited separation upon cooling.
- unsuitable polymers included Carbomer, Salcare SC96 ® and Pemulen TR-1.
- Samples 12, 14, 15 and 17 were stable utilizing respectively Aristoflex AVC ® , xanthan gum and Viscolam AT 100/P.
- the Transmission Intensity for the xanthan gum was outside the Acceptability Range. See Table VII.
- the Viscolam AT ® 100/P (Sodium Acrylate/Sodium Acryloyldimethyltaurate Copolymer) in Sample 15 exhibited excellent Transmission Intensity Opacity at all angles and Reflection Intensity fell within the parameters necessary to achieve both soft focus and radiance.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0506504-6A BRPI0506504A (en) | 2004-01-23 | 2005-01-12 | cosmetic compositions |
JP2006550012A JP2007518761A (en) | 2004-01-23 | 2005-01-12 | Taurate-containing pigmented cosmetic composition with soft focus and shine |
AU2005205898A AU2005205898B8 (en) | 2004-01-23 | 2005-01-12 | Taurate formulated pigmented cosmetic composition exhibiting radiance with soft focus |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53866404P | 2004-01-23 | 2004-01-23 | |
US60/538,664 | 2004-01-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005070384A1 true WO2005070384A1 (en) | 2005-08-04 |
Family
ID=34807207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/000436 WO2005070384A1 (en) | 2004-01-23 | 2005-01-12 | Taurate formulated pigmented cosmetic composition exhibitiing radiance with soft focus |
Country Status (7)
Country | Link |
---|---|
JP (1) | JP2007518761A (en) |
AR (1) | AR047737A1 (en) |
AU (1) | AU2005205898B8 (en) |
BR (1) | BRPI0506504A (en) |
TW (1) | TW200536569A (en) |
WO (1) | WO2005070384A1 (en) |
ZA (1) | ZA200605884B (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1776985A3 (en) * | 2005-10-24 | 2007-08-01 | Johnson and Johnson Consumer Companies, Inc. | Compositions comprising polymeric emulsifiers and methods of using the same |
EP1935399A2 (en) * | 2006-12-20 | 2008-06-25 | L'oreal | Cosmetic product containing silicone compounds and an amphiphilic polymer |
EP2262469A1 (en) * | 2008-04-15 | 2010-12-22 | Immanence Integrale Dermo Correction Inc. | Skin care compositions and methods of use thereof |
EP2529725A1 (en) * | 2011-05-31 | 2012-12-05 | Lvmh Recherche | Cosmetic care or make-up composition containing powders and manufacturing method |
WO2014019840A3 (en) * | 2012-08-01 | 2014-07-31 | Dow Corning Corporation | Aqueous silicone dispersions and their preparation |
US8933134B2 (en) | 2010-06-09 | 2015-01-13 | L'oreal | Compositions containing agar and a softening agent |
US9345649B2 (en) | 2006-12-21 | 2016-05-24 | Avon Products, Inc. | Cosmetic composition containing novel fractal particle-based gels |
US9452114B2 (en) | 2009-07-20 | 2016-09-27 | L'oreal | Emulsion containing a dispersion of bismuth oxychloride |
US9968525B2 (en) | 2007-12-27 | 2018-05-15 | Avon Products, Inc. | Optical blurring pigment composition suitable for use in cosmetics |
EP2958541B1 (en) | 2013-02-25 | 2018-12-26 | L'Oréal | Gel-type cosmetic composition |
CN110139637A (en) * | 2016-12-28 | 2019-08-16 | Lvmh研究公司 | Cosmetic composition with general optical correction |
EP3148646B1 (en) | 2014-05-28 | 2019-08-21 | L'Oréal | Cosmetic composition for make up and for taking care of keratin materials |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI468185B (en) * | 2007-12-27 | 2015-01-11 | Avon Prod Inc | Gel technology suitable for use in cosmetic compositions |
JP6567262B2 (en) * | 2014-09-30 | 2019-08-28 | 小林製薬株式会社 | Composition for external use |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020155076A1 (en) * | 2000-12-23 | 2002-10-24 | Ghita Lanzendorfer | Gel creams in the form of O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers |
WO2003022236A1 (en) * | 2001-09-12 | 2003-03-20 | Unilever Plc | Thickened cosmetic compositions comprising a taurate copolymer |
FR2834450A1 (en) * | 2002-01-04 | 2003-07-11 | Oreal | Composition useful for cosmetic purposes comprises an aqueous dispersion of silicone copolymer particles containing a sulfonic acid polymer and/or an organic powder |
WO2003099253A1 (en) * | 2002-05-29 | 2003-12-04 | Unilever Plc | Personal care compositions with hydroxy amine neutralized polymers |
WO2004039338A1 (en) * | 2002-10-31 | 2004-05-13 | Merz Pharma Gmbh & Co. Kgaa | O/w emulsion with a combination of a silicone-based emulsifier and one or several surfactants, selected from anionic and cationic surfactants, the production and use therof |
EP1468670A1 (en) * | 2003-04-14 | 2004-10-20 | L'oreal | Ein Lichtschutzmittel, welches mindestens ein Akrylamido-2-methylpropan sulfonsäure Polymer und 4,4-Diarylbutadien enthält, und die Verwendung davon |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5798205A (en) * | 1980-12-09 | 1982-06-18 | Pola Chem Ind Inc | Cosmetic giving durable make-up |
FR2751542B1 (en) * | 1996-07-29 | 1998-09-11 | Oreal | SKIN OR HAIR PROTECTION COMPOSITION CONTAINING NANOPIGMENTS AND AN ELASTOMERIC SOLID ORGANOPOLYSILOXANE ASSOCIATED WITH A FATTY PHASE |
FR2787460A1 (en) * | 1998-12-18 | 2000-06-23 | Oreal | STABLE COSMETIC COMPOSITION COMPRISING A POLY POLYMER (2-ACRYLAMIDO 2-METHYL-PROPANE SULFONIC), UNCOATED SOLID PARTICLES AND AN OIL-DISPERSANT POLYMER |
FR2794125B1 (en) * | 1999-05-26 | 2001-07-20 | Oreal | COMPOSITION IN THE FORM OF AN OIL-IN-WATER EMULSION AND ITS USES, IN PARTICULAR COSMETICS |
DE60210737T2 (en) * | 2002-01-04 | 2007-01-18 | L'oreal S.A. | A silicone copolymer and either a polymer of an ethylenically unsaturated monomer having sulfonic groups or an organic powder-containing composition; their uses, especially in cosmetics |
-
2005
- 2005-01-12 ZA ZA200605884A patent/ZA200605884B/en unknown
- 2005-01-12 JP JP2006550012A patent/JP2007518761A/en active Pending
- 2005-01-12 BR BRPI0506504-6A patent/BRPI0506504A/en not_active IP Right Cessation
- 2005-01-12 WO PCT/EP2005/000436 patent/WO2005070384A1/en active Application Filing
- 2005-01-12 AU AU2005205898A patent/AU2005205898B8/en not_active Ceased
- 2005-01-21 TW TW94101855A patent/TW200536569A/en unknown
- 2005-01-21 AR ARP050100225 patent/AR047737A1/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020155076A1 (en) * | 2000-12-23 | 2002-10-24 | Ghita Lanzendorfer | Gel creams in the form of O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers |
WO2003022236A1 (en) * | 2001-09-12 | 2003-03-20 | Unilever Plc | Thickened cosmetic compositions comprising a taurate copolymer |
FR2834450A1 (en) * | 2002-01-04 | 2003-07-11 | Oreal | Composition useful for cosmetic purposes comprises an aqueous dispersion of silicone copolymer particles containing a sulfonic acid polymer and/or an organic powder |
WO2003099253A1 (en) * | 2002-05-29 | 2003-12-04 | Unilever Plc | Personal care compositions with hydroxy amine neutralized polymers |
WO2004039338A1 (en) * | 2002-10-31 | 2004-05-13 | Merz Pharma Gmbh & Co. Kgaa | O/w emulsion with a combination of a silicone-based emulsifier and one or several surfactants, selected from anionic and cationic surfactants, the production and use therof |
EP1468670A1 (en) * | 2003-04-14 | 2004-10-20 | L'oreal | Ein Lichtschutzmittel, welches mindestens ein Akrylamido-2-methylpropan sulfonsäure Polymer und 4,4-Diarylbutadien enthält, und die Verwendung davon |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1776985A3 (en) * | 2005-10-24 | 2007-08-01 | Johnson and Johnson Consumer Companies, Inc. | Compositions comprising polymeric emulsifiers and methods of using the same |
EP1935399A2 (en) * | 2006-12-20 | 2008-06-25 | L'oreal | Cosmetic product containing silicone compounds and an amphiphilic polymer |
FR2910284A1 (en) * | 2006-12-20 | 2008-06-27 | Oreal | COSMETIC PRODUCT COMPRISING SILICONE COMPOUNDS AND AN AMPHIPHILIC POLYMER |
EP1935399A3 (en) * | 2006-12-20 | 2008-09-17 | L'oreal | Cosmetic product containing silicone compounds and an amphiphilic polymer |
US9345649B2 (en) | 2006-12-21 | 2016-05-24 | Avon Products, Inc. | Cosmetic composition containing novel fractal particle-based gels |
US9561163B2 (en) | 2006-12-21 | 2017-02-07 | Avon Products, Inc. | Cosmetic composition containing novel fractal particle-based gels |
US9968525B2 (en) | 2007-12-27 | 2018-05-15 | Avon Products, Inc. | Optical blurring pigment composition suitable for use in cosmetics |
EP2262469A4 (en) * | 2008-04-15 | 2013-12-04 | Immanence Integrale Dermo Correction Inc | Skin care compositions and methods of use thereof |
EP2262469A1 (en) * | 2008-04-15 | 2010-12-22 | Immanence Integrale Dermo Correction Inc. | Skin care compositions and methods of use thereof |
US9956147B2 (en) | 2009-07-20 | 2018-05-01 | L'oreal | Emulsion containing a dispersion of bismuth oxychloride |
US9452114B2 (en) | 2009-07-20 | 2016-09-27 | L'oreal | Emulsion containing a dispersion of bismuth oxychloride |
US8933134B2 (en) | 2010-06-09 | 2015-01-13 | L'oreal | Compositions containing agar and a softening agent |
EP2529725A1 (en) * | 2011-05-31 | 2012-12-05 | Lvmh Recherche | Cosmetic care or make-up composition containing powders and manufacturing method |
FR2975905A1 (en) * | 2011-05-31 | 2012-12-07 | Lvmh Rech | COSMETIC COMPOSITION FOR CARE OR MAKE-UP CONTAINING POWDERS AND METHOD OF MANUFACTURE |
US9504748B2 (en) | 2012-08-01 | 2016-11-29 | Dow Corning Corporation | Aqueous silicone dispersions and their preparation |
WO2014019840A3 (en) * | 2012-08-01 | 2014-07-31 | Dow Corning Corporation | Aqueous silicone dispersions and their preparation |
EP2958541B1 (en) | 2013-02-25 | 2018-12-26 | L'Oréal | Gel-type cosmetic composition |
EP3148646B1 (en) | 2014-05-28 | 2019-08-21 | L'Oréal | Cosmetic composition for make up and for taking care of keratin materials |
EP3148646B2 (en) † | 2014-05-28 | 2022-08-03 | L'Oréal | Cosmetic composition for make up and for taking care of keratin materials |
CN110139637A (en) * | 2016-12-28 | 2019-08-16 | Lvmh研究公司 | Cosmetic composition with general optical correction |
Also Published As
Publication number | Publication date |
---|---|
JP2007518761A (en) | 2007-07-12 |
TW200536569A (en) | 2005-11-16 |
ZA200605884B (en) | 2008-05-28 |
BRPI0506504A (en) | 2007-02-27 |
AR047737A1 (en) | 2006-02-15 |
AU2005205898A1 (en) | 2005-08-04 |
AU2005205898B2 (en) | 2008-05-08 |
AU2005205898B8 (en) | 2008-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7695726B2 (en) | Pigmented cosmetic composition exhibiting radiance with soft focus | |
JP5455003B2 (en) | Cosmetic W / O type emulsion containing organic sunscreen and conjugated linoleic acid | |
US20050249684A1 (en) | Taurate formulated pigmented cosmetic composition exhibiting radiance with soft focus | |
AU2005205898B8 (en) | Taurate formulated pigmented cosmetic composition exhibiting radiance with soft focus | |
WO2003022234A1 (en) | Cosmetic composition with organic sunscreen and porous powder particles | |
EP2094233B1 (en) | Single-crystal platy barium sulfate in cosmetic compositions | |
JP5544304B2 (en) | Cationic copolymers formulated with colored cosmetic compositions that give a soft focus shine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006/05884 Country of ref document: ZA Ref document number: 200605884 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 862/MUMNP/2006 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006550012 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005205898 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2005205898 Country of ref document: AU Date of ref document: 20050112 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005205898 Country of ref document: AU |
|
122 | Ep: pct application non-entry in european phase | ||
ENP | Entry into the national phase |
Ref document number: PI0506504 Country of ref document: BR |